person reading Dr. Robert M. Hershberg, M.D.,PhD's salary history.

Historical salary details - Dr. Robert M. Hershberg, M.D.,PhD, Independent Director, Adaptive Biotechnologies Corp

Dr. Robert M. Hershberg, M.D.,PhD is the Independent Director of Adaptive Biotechnologies Corp. They also hold 3 other positions in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A, Fate Therapeutics Inc and HilleVax Inc.

Dr. Robert M. Hershberg, M.D.,Phd

Independent Director

$ 676.5 K
Gross Remuneration
  • Current Company

    Adaptive Biotechnologies Corp
YEAR COMPANY POSITION SALARY INCREMENT
2024 Adaptive Biotechnologies Corp Independent Director 325 K 0.0 %
2024 Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Chairman of the Board 316.5 K 4.5 %
2024 Fate Therapeutics Inc Independent Director 35.0 K -
2024 HilleVax Inc Chairman of the Board, President and Chief Executi - -
2023 Adaptive Biotechnologies Corp Independent Director 325.0 K 4.4 %
2023 Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Independent Director 302.7 K 3.3 %
2023 Fate Therapeutics Inc Independent Director 221.8 K -
2023 Fate Therapeutics Inc Independent Director - -
2022 Adaptive Biotechnologies Corp Independent Director 311.3 K 1.6 %
2022 Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Independent Director 293.1 K -18.4 %
2022 ARS Pharmaceuticals Inc Independent Director 142.7 K -
2022 Nanostring Technologies Inc Independent Director 83.2 K -69.9 %
2022 Fate Therapeutics Inc Independent Director - -
2022 HilleVax Inc Chairman of the Board, President and Chief Executi - -
2021 Fate Therapeutics Inc Independent Director 435.2 K -40.8 %
2021 Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Independent Director 359.3 K -48.5 %
2021 Adaptive Biotechnologies Corp Independent Director 306.3 K 40.9 %
2021 Nanostring Technologies Inc Independent Director 276.3 K 25.1 %
2021 HilleVax Inc Chairman of the Board, President and Chief Executi - -
2020 Fate Therapeutics Inc Independent Director 735.2 K -
2020 Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Independent Director 697.7 K -
2020 Nanostring Technologies Inc Independent Director 220.9 K 13.3 %
2020 Adaptive Biotechnologies Corp Independent Director 217.5 K 144.6 %
2019 Nanostring Technologies Inc Independent Director 195.0 K 128.4 %
2019 Adaptive Biotechnologies Corp Independent Director 88.9 K 42.0 %
2018 Nanostring Technologies Inc Independent Director 85.4 K -37.6 %
2018 Adaptive Biotechnologies Corp Independent Director 62.6 K -
2017 Nanostring Technologies Inc Independent Director 136.7 K 49.3 %
2016 Nanostring Technologies Inc Independent Director 91.6 K -15.2 %
2015 Nanostring Technologies Inc Independent Director 108.0 K -
2014 Nanostring Technologies Inc Independent Director - -